IBDEI0S1 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28188,2)
 ;;=^88074
 ;;^UTILITY(U,$J,358.3,28189,0)
 ;;=D69.6^^105^1372^24
 ;;^UTILITY(U,$J,358.3,28189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28189,1,3,0)
 ;;=3^Thrombocytopenia, unspecified
 ;;^UTILITY(U,$J,358.3,28189,1,4,0)
 ;;=4^D69.6
 ;;^UTILITY(U,$J,358.3,28189,2)
 ;;=^5002370
 ;;^UTILITY(U,$J,358.3,28190,0)
 ;;=M31.1^^105^1372^25
 ;;^UTILITY(U,$J,358.3,28190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28190,1,3,0)
 ;;=3^Thrombotic microangiopathy
 ;;^UTILITY(U,$J,358.3,28190,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,28190,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,28191,0)
 ;;=D69.9^^105^1372^11
 ;;^UTILITY(U,$J,358.3,28191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28191,1,3,0)
 ;;=3^Hemorrhagic condition, unspecified
 ;;^UTILITY(U,$J,358.3,28191,1,4,0)
 ;;=4^D69.9
 ;;^UTILITY(U,$J,358.3,28191,2)
 ;;=^5002371
 ;;^UTILITY(U,$J,358.3,28192,0)
 ;;=I80.9^^105^1372^20
 ;;^UTILITY(U,$J,358.3,28192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28192,1,3,0)
 ;;=3^Phlebitis and thrombophlebitis of unspecified site
 ;;^UTILITY(U,$J,358.3,28192,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,28192,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,28193,0)
 ;;=Z31.5^^105^1373^4
 ;;^UTILITY(U,$J,358.3,28193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28193,1,3,0)
 ;;=3^Genetic Counseling
 ;;^UTILITY(U,$J,358.3,28193,1,4,0)
 ;;=4^Z31.5
 ;;^UTILITY(U,$J,358.3,28193,2)
 ;;=^5062838
 ;;^UTILITY(U,$J,358.3,28194,0)
 ;;=Z51.11^^105^1373^2
 ;;^UTILITY(U,$J,358.3,28194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28194,1,3,0)
 ;;=3^Antineoplastic Chemotherapy
 ;;^UTILITY(U,$J,358.3,28194,1,4,0)
 ;;=4^Z51.11
 ;;^UTILITY(U,$J,358.3,28194,2)
 ;;=^5063061
 ;;^UTILITY(U,$J,358.3,28195,0)
 ;;=Z71.3^^105^1373^3
 ;;^UTILITY(U,$J,358.3,28195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28195,1,3,0)
 ;;=3^Dietary counseling and surveillance
 ;;^UTILITY(U,$J,358.3,28195,1,4,0)
 ;;=4^Z71.3
 ;;^UTILITY(U,$J,358.3,28195,2)
 ;;=^5063245
 ;;^UTILITY(U,$J,358.3,28196,0)
 ;;=Z71.89^^105^1373^8
 ;;^UTILITY(U,$J,358.3,28196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28196,1,3,0)
 ;;=3^Specified Counseling NEC
 ;;^UTILITY(U,$J,358.3,28196,1,4,0)
 ;;=4^Z71.89
 ;;^UTILITY(U,$J,358.3,28196,2)
 ;;=^5063253
 ;;^UTILITY(U,$J,358.3,28197,0)
 ;;=Z51.89^^105^1373^1
 ;;^UTILITY(U,$J,358.3,28197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28197,1,3,0)
 ;;=3^Aftercare NEC
 ;;^UTILITY(U,$J,358.3,28197,1,4,0)
 ;;=4^Z51.89
 ;;^UTILITY(U,$J,358.3,28197,2)
 ;;=^5063065
 ;;^UTILITY(U,$J,358.3,28198,0)
 ;;=Z12.39^^105^1373^5
 ;;^UTILITY(U,$J,358.3,28198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28198,1,3,0)
 ;;=3^Malig Neop of Breast Screening
 ;;^UTILITY(U,$J,358.3,28198,1,4,0)
 ;;=4^Z12.39
 ;;^UTILITY(U,$J,358.3,28198,2)
 ;;=^5062686
 ;;^UTILITY(U,$J,358.3,28199,0)
 ;;=Z12.4^^105^1373^6
 ;;^UTILITY(U,$J,358.3,28199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28199,1,3,0)
 ;;=3^Malig Neop of Cervix Screening
 ;;^UTILITY(U,$J,358.3,28199,1,4,0)
 ;;=4^Z12.4
 ;;^UTILITY(U,$J,358.3,28199,2)
 ;;=^5062687
 ;;^UTILITY(U,$J,358.3,28200,0)
 ;;=Z12.12^^105^1373^7
 ;;^UTILITY(U,$J,358.3,28200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28200,1,3,0)
 ;;=3^Malig Neop of Rectum Screening
 ;;^UTILITY(U,$J,358.3,28200,1,4,0)
 ;;=4^Z12.12
 ;;^UTILITY(U,$J,358.3,28200,2)
 ;;=^5062682
 ;;^UTILITY(U,$J,358.3,28201,0)
 ;;=C61.^^105^1374^11
 ;;^UTILITY(U,$J,358.3,28201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28201,1,3,0)
 ;;=3^Malignant neoplasm of prostate
 ;;^UTILITY(U,$J,358.3,28201,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,28201,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,28202,0)
 ;;=C62.11^^105^1374^6
 ;;^UTILITY(U,$J,358.3,28202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28202,1,3,0)
 ;;=3^Malignant neoplasm of descended right testis
 ;;^UTILITY(U,$J,358.3,28202,1,4,0)
 ;;=4^C62.11
 ;;^UTILITY(U,$J,358.3,28202,2)
 ;;=^5001234
 ;;^UTILITY(U,$J,358.3,28203,0)
 ;;=C62.12^^105^1374^5
 ;;^UTILITY(U,$J,358.3,28203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28203,1,3,0)
 ;;=3^Malignant neoplasm of descended left testis
 ;;^UTILITY(U,$J,358.3,28203,1,4,0)
 ;;=4^C62.12
 ;;^UTILITY(U,$J,358.3,28203,2)
 ;;=^5001235
 ;;^UTILITY(U,$J,358.3,28204,0)
 ;;=C62.91^^105^1374^3
 ;;^UTILITY(U,$J,358.3,28204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28204,1,3,0)
 ;;=3^Malig neoplasm of right testis, unsp descended or undescended
 ;;^UTILITY(U,$J,358.3,28204,1,4,0)
 ;;=4^C62.91
 ;;^UTILITY(U,$J,358.3,28204,2)
 ;;=^5001237
 ;;^UTILITY(U,$J,358.3,28205,0)
 ;;=C62.92^^105^1374^2
 ;;^UTILITY(U,$J,358.3,28205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28205,1,3,0)
 ;;=3^Malig neoplasm of left testis, unsp descended or undescended
 ;;^UTILITY(U,$J,358.3,28205,1,4,0)
 ;;=4^C62.92
 ;;^UTILITY(U,$J,358.3,28205,2)
 ;;=^5001238
 ;;^UTILITY(U,$J,358.3,28206,0)
 ;;=C60.9^^105^1374^10
 ;;^UTILITY(U,$J,358.3,28206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28206,1,3,0)
 ;;=3^Malignant neoplasm of penis, unspecified
 ;;^UTILITY(U,$J,358.3,28206,1,4,0)
 ;;=4^C60.9
 ;;^UTILITY(U,$J,358.3,28206,2)
 ;;=^5001229
 ;;^UTILITY(U,$J,358.3,28207,0)
 ;;=C67.9^^105^1374^4
 ;;^UTILITY(U,$J,358.3,28207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28207,1,3,0)
 ;;=3^Malignant neoplasm of bladder, unspecified
 ;;^UTILITY(U,$J,358.3,28207,1,4,0)
 ;;=4^C67.9
 ;;^UTILITY(U,$J,358.3,28207,2)
 ;;=^5001263
 ;;^UTILITY(U,$J,358.3,28208,0)
 ;;=C64.2^^105^1374^7
 ;;^UTILITY(U,$J,358.3,28208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28208,1,3,0)
 ;;=3^Malignant neoplasm of left kidney, except renal pelvis
 ;;^UTILITY(U,$J,358.3,28208,1,4,0)
 ;;=4^C64.2
 ;;^UTILITY(U,$J,358.3,28208,2)
 ;;=^5001249
 ;;^UTILITY(U,$J,358.3,28209,0)
 ;;=C64.1^^105^1374^12
 ;;^UTILITY(U,$J,358.3,28209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28209,1,3,0)
 ;;=3^Malignant neoplasm of right kidney, except renal pelvis
 ;;^UTILITY(U,$J,358.3,28209,1,4,0)
 ;;=4^C64.1
 ;;^UTILITY(U,$J,358.3,28209,2)
 ;;=^5001248
 ;;^UTILITY(U,$J,358.3,28210,0)
 ;;=C65.1^^105^1374^13
 ;;^UTILITY(U,$J,358.3,28210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28210,1,3,0)
 ;;=3^Malignant neoplasm of right renal pelvis
 ;;^UTILITY(U,$J,358.3,28210,1,4,0)
 ;;=4^C65.1
 ;;^UTILITY(U,$J,358.3,28210,2)
 ;;=^5001251
 ;;^UTILITY(U,$J,358.3,28211,0)
 ;;=C65.2^^105^1374^8
 ;;^UTILITY(U,$J,358.3,28211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28211,1,3,0)
 ;;=3^Malignant neoplasm of left renal pelvis
 ;;^UTILITY(U,$J,358.3,28211,1,4,0)
 ;;=4^C65.2
 ;;^UTILITY(U,$J,358.3,28211,2)
 ;;=^5001252
 ;;^UTILITY(U,$J,358.3,28212,0)
 ;;=C66.1^^105^1374^14
 ;;^UTILITY(U,$J,358.3,28212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28212,1,3,0)
 ;;=3^Malignant neoplasm of right ureter
 ;;^UTILITY(U,$J,358.3,28212,1,4,0)
 ;;=4^C66.1
 ;;^UTILITY(U,$J,358.3,28212,2)
 ;;=^5001254
 ;;^UTILITY(U,$J,358.3,28213,0)
 ;;=C66.2^^105^1374^9
 ;;^UTILITY(U,$J,358.3,28213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28213,1,3,0)
 ;;=3^Malignant neoplasm of left ureter
 ;;^UTILITY(U,$J,358.3,28213,1,4,0)
 ;;=4^C66.2
 ;;^UTILITY(U,$J,358.3,28213,2)
 ;;=^5001255
 ;;^UTILITY(U,$J,358.3,28214,0)
 ;;=C68.0^^105^1374^15
 ;;^UTILITY(U,$J,358.3,28214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28214,1,3,0)
 ;;=3^Malignant neoplasm of urethra
 ;;^UTILITY(U,$J,358.3,28214,1,4,0)
 ;;=4^C68.0
 ;;^UTILITY(U,$J,358.3,28214,2)
 ;;=^267266
 ;;^UTILITY(U,$J,358.3,28215,0)
 ;;=D09.0^^105^1374^1
 ;;^UTILITY(U,$J,358.3,28215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28215,1,3,0)
 ;;=3^Carcinoma in situ of bladder
 ;;^UTILITY(U,$J,358.3,28215,1,4,0)
 ;;=4^D09.0
 ;;^UTILITY(U,$J,358.3,28215,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,28216,0)
 ;;=C15.9^^105^1375^9
 ;;^UTILITY(U,$J,358.3,28216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28216,1,3,0)
 ;;=3^Malignant neoplasm of esophagus, unspecified
